癌症治疗一直是全球生物医药研究与临床应用的重点领域。癌症是由基因突变或基因组改变引发的疾病，使细胞获得逃逸凋亡与生长抑制信号的能力，造成细胞无限增殖并向全身扩散。
Cancer therapy has always been the focus of biomedical research and practice across the world. Cancer is a disease in which mutations or genomic changes enable cells to achieve a wide range of abilities in order to escape apoptosis and growth inhibition signals, enable cells to achieve a wide range of abilities in order to escape apoptosis and growth inhibition signals,
心血管疾病研究是全球生物医药领域的核心研究方向之一。心血管疾病多由血管内皮功能紊乱、脂质代谢异常及慢性炎症诱发，造成血管结构病变与血液循环障碍，以血管狭窄、动脉粥样硬化、血栓形成、心肌缺血损伤为主要病理特征。临床根据疾病类型、病灶位置与病情程度制定治疗方案，传统方式以手术干预与常规对症药物治疗为主。但传统疗法无法从根源逆转血管病变，且易产生耐药性与不良反应。
Cardiovascular disease research is one of the core directions of global biomedical research. Cardiovascular diseases are caused by vascular endothelial dysfunction, lipid metabolism disorders and chronic inflammation, leading to abnormal vascular structure and impaired blood circulation. It is mainly characterized by vascular stenosis, atherosclerosis, thrombosis and myocardial ischemic injury. Clinical treatment plans vary according to disease type, lesion location and disease severity. Traditional treatments mainly include
内分泌疾病研究在现代生物医药体系中占据重要地位。内分泌疾病因激素分泌异常或信号通路调控紊乱引发，打破机体内部稳态，诱发多系统生理代谢异常，核心特征为激素水平失衡、内分泌反馈调节失常。临床依据疾病分型、激素水平及患者身体状态制定干预方案，传统治疗以激素调节、对症支持疗法为主。
Endocrine disease research occupies an important position in modern biomedicine. Endocrine diseases are metabolic disorders caused by abnormal hormone secretion or signal pathway dysfunction, which break the body’s internal homeostasis and lead to multi-system physiological disorders. It is characterized by hormone imbalance and abnormal regulation of endocrine feedback loops. Clinical intervention schemes are formulated based on disease classification, hormone level changes and patient physical conditions. Traditional treatments mainly adopt hormone regulation and symptomatic support therapy. However,
感染性疾病研究是全球生物医药领域经久不衰的重要研究方向。感染性疾病由细菌、病毒、真菌、寄生虫等病原体侵入机体并增殖引发，诱发免疫应答与组织损伤，以病原体复制增殖、持续性感染、全身性炎症反应为主要特征。临床根据病原体类型、感染部位与感染程度制定治疗方案，传统手段以抗菌、
Infectious disease research is a vital and enduring field in global biomedical research. Infectious diseases are pathological damages caused by the invasion and proliferation of pathogens such as bacteria, viruses, fungi and parasites in the host, which trigger immune responses and tissue inflammatory injuries. It is characterized by pathogen replication, persistent infection and systemic inflammatory response. Clinical treatment strategies depend on pathogen type,
炎症与免疫疾病是当前生物医药最活跃的前沿研究领域之一。炎症免疫类疾病由免疫细胞异常活化、炎症通路调控紊乱导致，引发过度炎症瀑布反应与自体免疫损伤，以持续性慢性炎症、免疫耐受失常为主要特征。临床根据炎症程度、免疫状态及疾病类型制定治疗方案，传统治疗以非甾体抗炎药、广谱免疫抑制剂为主。但传统药物易造成全身性免疫抑制、副作用较多，无法精准调控免疫平衡。
Inflammation and immunological disease research is one of the most active frontiers in current biomedical research. Immune and inflammatory diseases result from abnormal activation of immune cells and dysregulated inflammatory signaling pathways, leading to excessive inflammatory cascade response and autoimmune tissue damage. It is mainly manifested as persistent chronic inflammation and abnormal immune tolerance.
随着全球慢性代谢病发病率持续升高，代谢疾病研究已成为生物医药重要研究方向。代谢疾病由遗传因素或生活方式诱发代谢酶、信号通路功能异常，导致机体糖、脂、能量代谢紊乱，以代谢稳态失衡、代谢产物异常蓄积为核心特征。临床依据生化指标、疾病类型及并发症制定干预方案，传统治疗以饮食调控、基础代谢调节药物为主。但传统干预仅能改善表层症状，无法从根源纠正代谢缺陷，
Metabolic disease research has become an important research direction with the global increase of chronic metabolic disorders. Metabolic diseases are caused by genetic factors or lifestyle-induced dysfunction of metabolic enzymes and signaling pathways, resulting in disorders of glucose, lipid and energy metabolism in the body. They are characterized by metabolic homeostasis imbalance and abnormal accumulation of metabolic products.
癫痫、肌张力障碍等多种神经系统疾病的发病机制常与皮层内抑制功能紊乱相关，可通过针对性调控该功能的方式进行治疗干预。帕金森病是典型的神经退行性疾病，主要病理改变为基底节γ-氨基丁酸活性亢进、黑质纹状体通路多巴胺缺失，临床典型症状包含肌强直、
A variety of neurological disorders such as epilepsy and dystonia are commonly attributed to dysfunctional intracortical inhibition and can be treated with targeted interventions that regulate this inhibitory function. Parkinson’s disease is a typical neurodegenerative disease pathologically characterized by elevated GABA activity in the basal ganglia and the loss of dopamine in the nigrostriatum, with typical clinical manifestations including rigidity, resting tremor, accelerating gait and fixed facial expression.
